Dr. Melinda Telli, MD
Claim this profileStanford Cancer Institute Palo Alto
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
17 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER negative
PR negative
2Breast Cancer
HER2 positive
ER negative
PR negative
Affiliated Hospitals
Clinical Trials Melinda Telli, MD is currently running
HMBD-002 + Pembrolizumab
for Cancer
This is a phase 1/2, open-label, multi-center, first-in-human, two-stage (Part 1: dose escalation and Part 2: dose expansion) study evaluating multiple doses and schedules of intravenously (IV) administered HMBD-002, with or without pembrolizumab KEYTRUDA®, in patients with advanced solid tumors (i.e., locally advanced and unresectable, or metastatic).
Recruiting1 award Phase 113 criteria
Talazoparib
for Advanced Breast Cancer
This purpose of this study is to test if talazoparib is safe and evaluate its response to advanced breast cancer associated with mutation of gene called PALB.
Recruiting1 award Phase 219 criteria
More about Melinda Telli, MD
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Melinda Telli, MD has experience with
- Pembrolizumab
- Placebo
- Niraparib
- Talazoparib Tosylate
- Capecitabine
- HMBD-002
Breakdown of trials Melinda Telli, MD has run
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melinda Telli, MD specialize in?
Melinda Telli, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER negative.
Is Melinda Telli, MD currently recruiting for clinical trials?
Yes, Melinda Telli, MD is currently recruiting for 7 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Melinda Telli, MD has studied deeply?
Yes, Melinda Telli, MD has studied treatments such as Pembrolizumab, Placebo, Niraparib.
What is the best way to schedule an appointment with Melinda Telli, MD?
Apply for one of the trials that Melinda Telli, MD is conducting.
What is the office address of Melinda Telli, MD?
The office of Melinda Telli, MD is located at: Stanford Cancer Institute Palo Alto, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford Cancer Institute Palo Alto.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.